(2‐Amino­ethoxy)­bis(2‐thienyl)­boron

In the five‐membered ring in the title compound, (2‐amino­ethoxy)­bis(2‐thienyl)­boron, C₁₀H₁₂BNOS_2, the B atom is four‐coordinate with dimensions N—B 1.654 (3), O—B 1.479 (3), and C—B 1.606 (3) and 1.609 (3) Å. An intermolecular hydrogen bond between an amino H atom and the ethoxy O atom links the mol­ecules into infinite chains along the a axis. Only one of the two amino H atoms is involved in hydrogen bonding because there is only the one acceptor atom, the ethoxy O atom, and the molecular geometry precludes formation of a second hydrogen bond by the second amino H atom.     

2,2′‐Anhydro‐1‐(3′,5′‐di‐O‐acetyl‐β‐D‐arabinofuranosyl)uracil,a cyclouridine nucleoside with a C4′‐endo furanosyl conformation

2,2′‐Anhydro‐1‐(3′,5′‐di‐O‐acetyl‐β‐D‐arabinofuranosyl)uracil, C₁₃H₁₄N₂O₇, was obtained by refluxing 2′,3′‐O‐(methoxymethylene)uridine in acetic anhydride. The structure exhibits a nearly perfect C4′‐endo (⁴E) conformation. The best four‐atom plane of the five‐membered furanose ring is O—C—C—C, involving the C atoms of the fused five‐membered oxazolidine ring, and the torsion angle is only −0.4 (2)°. The oxazolidine ring is essentially coplanar with the six‐membered uracil ring [r.m.s. deviation = 0.012 (5) Å and dihedral angle = −3.2 (3)°]. The conformation at the exocyclic C—C bond is gauche–trans which is stabilized by various C—H...π and C—O...π interactions.     

N‐{4‐Bromo‐2‐[(3‐bromo‐1‐phenylsulfonyl‐1H‐indol‐2‐yl)methyl]‐5‐methoxyphenyl}acetamide

In the title compound, C₂₄H₂₀Br₂N₂O₄S, the indole ring system is planar and the S atom has a distorted tetrahedral configuration. The sulfonyl‐bound phenyl ring is orthogonal to the indole ring system and the conformation of the phenyl­sulfonyl substituent with respect to the indole moiety is influenced by intramolecular C—H⃛O hydrogen bonds involving the two sulfonyl O atoms. The mean plane through the acetyl­amido group makes a dihedral angle of 57.0 (1)° with the phenyl ring of the benzyl moiety. In the crystal, glide‐related mol­ecules are linked together by N—H⃛O hydrogen bonds and C—H⃛π interactions to form molecular chains, which extend through the crystal. Inversion‐related chains are interlinked by C—H⃛π interactions to form molecular layers parallel to the bc plane. These layers are interconnected through π–π interactions involving the five‐ and six‐membered rings of the indole moiety.     

17‐Oxo‐16‐(2‐pyridyl­methyl­ene)­androst‐5‐en‐3β‐ol monohydrate

The title compound, C₂₅H₃₁NO₂·H₂O, has the outer two six‐membered rings in chair conformations, while the central ring is in an 8β,9α‐half‐chair conformation. The five‐membered ring adopts a 13,14‐half‐chair conformation. The pyridyl­methyl­ene moiety has an E configuration with respect to the carbonyl group at position 17. The structure is stabilized by intermolecular O—H?N and O—H?O hydrogen bonds.     

1,4,4‐Tri­methyl‐9‐phenyl‐8‐oxa‐9‐aza­bi­cyclo­[3.2.2]­non‐6‐en‐2‐one

The structure of the adduct of eucarvone with nitro­so­benzene, C₁₆H₁₉NO₂, is reported. The [3.2.2] bicyclic system corresponds to two seven‐membered rings in boat and distorted chair conformations and a six‐membered ring that adopts a distorted boat conformation. No conjugation is observed between the phenyl group and the N—O system. The packing is directed mainly by a C?O hydrogen bond, C—H?O‐(1 ? x, ?y, z) and by intermolecular C—H?π interactions.     

4,4,6,6‐Tetra­chloro‐2,2‐(ethyl­ene­di­oxy­di‐o‐phenyl­enedi­imino)‐2λ5,4λ5,6λ5‐cyclo­triphosphazene

The title ligand, C₁₄H₁₄Cl₄N₅O₂P₃, is a cyclo­phosphazene lariat (PNP pivot) ether with a spiro‐cyclic 11‐membered macrocyclic ring containing two ether O and two N atoms; the phosphazene ring is nearly planar. The macrocyclic ring contains a four‐centred (trifurcate) N—H⋯O/N—H⋯N hydrogen bond, and the relative inner‐hole size of the macrocycle is ∼1.14 Å in radius. The mol­ecules are linked about inversion centres by N—H⋯N hydrogen bonds into centrosymmetric dimers.     

Di‐μ‐methoxo‐bis({N,N′‐bis­[2‐(3,5‐di­methyl­pyrazol‐1‐yl)­ethyl]­amine‐κ3N}copper(II)) bis­(hexa­fluoro­phosphate)

The title compound, [Cu₂(C₁₄H₂₃N₅)₂(CH₃O)₂](PF₆)₂, has a doubly methoxo‐bridged centrosymmetric copper dimer cation involving two tridentate bis­(pyrazolyl)­amine ligands. The geometry of each Cu^II atom is a distorted square pyramid with two N atoms of the pyrazole in bis­[2‐(3,5‐di­methyl‐1‐pyrazolyl)­ethyl]­amine (bpea) and two μ₂‐bridging O atoms of the methoxo ligands forming the basal plane, and the amine N atom occupying the axial position. In the bridging plane, the Cu—O bond lengths are 1.940 (4) and 1.942 (4) Å, and the bond angles for O—Cu—O and Cu—O—Cu are 76.1 (2) and 103.9 (2)°, respectively. The Cu?Cu distance is 3.058 (1) Å. The central four‐membered ring lies on an inversion centre.     

tert‐Butyl (3S,6R,9R)‐(5‐oxo‐3‐{[1(R)‐phenyl­ethyl]­carbamoyl}‐1,2,3,5,6,7,8,8a‐octa­hydro­indolizin‐6‐yl)­carbamate monohydrate at 95 K

The asymmetric unit of the title compound, C₂₂H₃₁N₃O₄·H₂O, incorporates one water mol­ecule, which is hydrogen bonded to the 3‐oxo O atom of the indolizidinone system. The two rings of the peptidomimetic mol­ecule are trans‐fused, with the six‐membered ring having a slightly distorted half‐chair conformation and the five‐membered ring having a perfect envelope conformation. The structure is stabilized by intermolecular O—H?O interactions between the water and adjacent peptide mol­ecules, and by N—H?O interactions between the peptide mol­ecules, which link the mol­ecules into infinite chains.     

4,4,6,6‐Tetra­chloro‐2,2‐(propyl­ene­dioxy­di‐o‐phenyl­enedi­imino)‐2λ5,4λ5,6λ5‐cyclotriphosphazene

The title compound, C₁₅H₁₆Cl₄N₅O₂P₃, is a cyclo­phosphazenic lariat (PNP‐pivot) ether with a spiro‐cyclic 12‐membered macrocyclic ligand containing two ether O and two N atoms; the phosphazene ring is nearly planar. In the macrocyclic ring, there is a four‐center (trifurcate) N—H⋯O/N—H⋯N hydrogen bond. The relative inner‐hole size of the macrocycle is estimated as approximately 0.95 Å.     

3′,4′‐Bis(4‐chloro­phenyl)­spiro­[chroman‐3,5′(4′H)‐isoxazol]‐4‐one

The title compound, C₂₃H₁₅Cl₂NO₃, crystallizes with two independent mol­ecules in the asymmetric unit. The chroman­one moiety consists of a benzene ring fused with a six‐membered heterocyclic ring which adopts a sofa conformation. The five‐membered spiro­isoxazoline ring is in an envelope conformation. The p‐chloro­phenyl rings bridged by the five‐membered ring are nearly perpendicular to each other. The chromanone moiety of one mol­ecule packs into the cavity formed by the p‐chloro­phenyl rings of a second mol­ecule through the formation of C—H?π interactions. The structure is stabilized by weak C—H?O, C—H?Cl and C—H?π interactions.     

Head‐to‐head dimers in the zwitterion of 1‐hydroxy‐1‐phosphono‐3‐(1‐piperidino)propylidene‐1‐phosphonate (PHPBP)

The title compound, C₈H₁₉NO₇P₂, is a member of the bis­phosphonate family of therapeutic compounds. PHPBP has inner‐salt character, consisting of a negatively charged PO₃ group and a positively charged N atom. The six‐membered piperidine ring adopts an almost‐perfect chair conformation. The hydroxyl group and the N atom have gauche and trans conformations in relation to the O—C—C—C—N backbone, respectively. Hydrogen bonding is the main contributor to the packing in the crystal, which consists of head‐to‐head dimers formed through phosphonyl–phosphonyl hydrogen bonds, while O—H⋯O and N—H⋯O interactions join the dimers into a plane parallel to crystallographic b and c axes.     

1‐Hydroxy‐1H‐benzo[d][1,2,6]oxazaborinin‐4(3H)‐one

The structure of the title compound, C₇H₆BNO₃, a new boron heterocycle, prepared by the condensation of (2‐ethoxycarbonylphenyl)boronic acid and hydroxylamine, reveals the specific mode of intramolecular condensation between a phenylboronic acid and an ortho hydroxamic acid substituent. The crystal structure shows that dehydration occurs to form a planar oxazaborinine ring possessing both phenol‐like B—O—H and lactam functional groups. In the extended structure, intermolecular hydrogen bonding generates a 14‐membered ring. To our knowledge, this is the first crystal structure determination involving a six‐membered ring that exhibits consecutive B—OH, O, NH, and C=O functional groups.     

(S)‐trans‐Cyclohexane‐1,2‐dicarboximide

The molecule of the title compound, C₈H₁₁NO₂, contains a strained bicyclic system with a significantly twisted imide chromophore. The five‐membered ring fragment containing the imide function is strongly puckered and adopts a half‐chair conformation. The six‐membered ring has a slightly distorted chair conformation. The mol­ecules are joined by strong N—H?O and weak C—H?O hydrogen bonds into infinite chains.     

Bis(μ‐succinato‐O,O′:O′′,O′′′)bis[bis(2‐amino‐1,3‐benzothiazole‐N3)copper(II)]

In the title dimeric complex, [Cu₂(C₄H₄O₄)₂(C₇H₆N₂S)₄], which possesses a centre of symmetry, the Cu atoms are enclosed in a 14‐membered ring. They adopt a distorted square‐bipyramidal (4+2) coordination. The four closest donor atoms are two N atoms of 2‐amino­benzo­thiazole ligands and two O atoms of the succinate carboxylate groups. They form a square‐planar cis arrangement, with an average Cu—N distance of 2.003 (3) Å and Cu—O distances of 1.949 (3) and 1.965 (3) Å. Two longer Cu—O bonds of 2.709 (3) and 2.613 (3) Å involving the remaining O atoms of the carboxylate groups complete the sixfold coordination of the Cu atoms. The H atoms of each amino group of the 2‐amino­benzo­thiazole molecules form intra‐ and inter­molecular N—H?O hydrogen bonds. A nearly perpendicular inter­molecular C—H?Cg interaction (Cg is the centroid of the imidazole ring) is observed. The intramolecular Cu?Cu distance is 6.384 (2) Å.     

Di‐μ‐sulfido‐bis[diaqua(18‐crown‐6)­barium(II)]–saccharin (1/2)

The mol­ecule of the title compound {systematic name: di‐μ‐sulfido‐bis[di­aqua(1,4,7,10,13,16‐hexaoxa­cyclo­octade­cane‐κ⁶O)barium(II)] bis­[1,2‐benzisothiazol‐3(2H)‐one 1,1‐dioxide]}, [Ba₂S₂(C₁₂H₂₄O₆)₂(H₂O)₄](C₇H₅NO₃S)₂, lies on an inversion centre. The Ba^II atom encapsulated by the 18‐crown‐6 ring is coordinated by the six O atoms of the crown, two water O atoms and two bridging S atoms. The four‐membered ring composed of the Ba^II atoms and the bridging S atoms makes a dihedral angle of 67.1 (1)° with the crown‐ether ring. The aromatic ring system of the saccharin moiety is essentially planar. The packing is built up from layers of the mol­ecules and is stabilized by three intermolecular O—H?O hydrogen bonds.     

Three sterically hindered 6‐amino‐5‐cyano‐2‐methyl‐4‐(1‐naphthyl)‐4H‐pyran‐3‐carboxylate derivatives

In the title compounds, 2‐methoxyethyl 6‐amino‐5‐cyano‐2‐methyl‐4‐(1‐naphthyl)‐4H‐pyran‐3‐carboxylate, C₂₁H₂₀N₂O₄, (II), isopropyl 6‐amino‐5‐cyano‐2‐methyl‐4‐(1‐naphthyl)‐4H‐pyran‐3‐carboxylate, C₂₁H₂₀N₂O₃, (III), and ethyl 6‐amino‐5‐cyano‐2‐methyl‐4‐(1‐naphthyl)‐4H‐pyran‐3‐carboxylate, C₂₀H₁₈N₂O₃, (IV), the heterocyclic pyran ring adopts a flattened boat conformation. In (II) and (III), the carbonyl group and a double bond of the heterocyclic ring are mutually anti, but in (IV) they are mutually syn. The ester O atoms in (II) and (III) and the carbonyl O atom in (IV) participate in intramolecular C—H...O contacts to form six‐membered rings. The dihedral angles between the naphthalene substituent and the closest four atoms of the heterocyclic ring are 73.3 (1), 71.0 (1) and 74.3 (1)° for (II)–(IV), respectively. In all three structures, only one H atom of the NH₂ group takes part in N—H...O [in (II) and (III)] or N—H...N [in (IV)] intermolecular hydrogen bonds, and chains [in (II) and (III)] or dimers [in (IV)] are formed. In (II), weak intermolecular C—H...O and C—H...N hydrogen bonds, and in (III) intermolecular C—H...O hydrogen bonds link the chains into ladders along the a axis.     

1‐(4,6‐Diethoxy­pyrimidin‐2‐yl)‐2‐thioxo‐2,3‐dihydro­pyrido[2,3‐d]pyrimidin‐4(1H)‐one

In the title compound, C₁₅H₁₅N₅O₃S, two parallel inter­molecular N—H⋯S hydrogen bonds, forming an eight‐membered ring, link two mol­ecules into a dimer unit; these dimer units linked into a chain of edge‐fused rings by weak C—H⋯O hydrogen bonds.     

(2R*,4S*)‐2‐(Pyridin‐3‐yl)‐2,3,4,5‐tetrahydro‐1H‐1‐benzazepin‐4‐ol: a three‐dimensional framework built from O—H...N,C—H...O and C—H...π(arene) hydrogen bonds

The title compound, C₁₅H₁₆N₂O, crystallizes in the space group P2₁2₁2₁ with Z′ = 1. The seven‐membered ring adopts a chair‐type conformation with the hydroxy and pyridyl substituents in equatorial sites. Molecules are linked into a three‐dimensional framework structure by a combination of O—H...N, C—H...O and C—H...π(arene) hydrogen bonds, but N—H...O and N—H...π(arene) interactions are absent from the structure. Comparisons are made with some related compounds.     

(2,2′‐Bipyridyl‐κ2N,N′)­bis­(salicyl­ato‐κ2O,O′)­zinc(II)

The asymmetric unit of the title compound, [Zn(C₇H₅O₃)₂(C₁₀H₈N₂)], contains one monomeric zinc complex. The Zn atom is coordinated to one 2,2′‐bipyridyl ligand via both N atoms and to two salicyl­ate anions (Hsal⁻) in a bidentate chelating manner involving carboxyl­ate O‐atom coordination. The complex exhibits a distorted octahedral geometry about the Zn^II atom, with the `apical' positions occupied by one of the two N atoms of the bipyridyl ligand and an O atom from one Hsal<sup>−</sup> ligand; the Zn atom is 0.168 (1) Å out of the `basal' plane. Two intramolecular six‐membered hydrogen‐bonded rings are present, generated from interactions between the carboxyl and hydroxyl groups of the salicyl­ate ligands. The crystal packing is governed by weak C—H⋯O and C—H⋯π interactions.     

2‐[(E)‐(4‐Hydroxy‐3‐methoxybenzylidene)amino]‐N‐(2‐methylphenyl)‐4,5,6,7‐tetrahydro‐1‐benzothiophene‐3‐carboxamide

The title compound, C₂₄H₂₄N₂O₃S, exhibits antifungal and antibacterial properties. The compound crystallizes with two molecules in the asymmetric unit, with one molecule exhibiting `orientational disorder' in the crystal structure with respect to the cyclohexene ring. The o‐toluidine groups in both molecules are noncoplanar with the respective cyclohexene‐fused thiophene ring. In both molecules, there is an intramolecular N—H...N hydrogen bond forming a pseudo‐six‐membered ring which locks the molecular conformation and eliminates conformational flexibility. The crystal structure is stabilized by O—H...O hydrogen bonds; both molecules in the asymmetric unit form independent chains, each such chain consisting of alternating `ordered' and `disordered' molecules in the crystal lattice.